Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells.

about

Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.Inhibitors of apoptosis: clinical implications in cancer.

P2860

Q40093716-40D30E32-EC86-497E-A01D-82F3D753B3D6 Q47607136-9C67323A-C477-4596-AB95-A995075DD80F

P2860

Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells.

Item

http://www.wikidata.org/entity/Q38750224

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Small Molecule Survivin Inhibi ...... inst Human Osteosarcoma Cells.

@en

type

Item

label

Small Molecule Survivin Inhibi ...... inst Human Osteosarcoma Cells.

@en

prefLabel

Small Molecule Survivin Inhibi ...... inst Human Osteosarcoma Cells.

@en

P1476

Small Molecule Survivin Inhibi ...... inst Human Osteosarcoma Cells.

@en

P2093

Li Wang

http://www.w3.org/2001/XMLSchema#string

Shufeng Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaohui Wang

http://www.w3.org/2001/XMLSchema#string

Zhimin Gu

http://www.w3.org/2001/XMLSchema#string

P2860

TNF-alpha induces two distinct caspase-8 activation pathways

Emerging roles of caspase-3 in apoptosis

Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma

Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairment.

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

Mcl-1 downregulation by YM155 contributes to its synergistic anti-tumor activities with ABT-263.

Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models.

Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.

Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro.

Prognostic factors in osteosarcoma: a critical review.

P304

401-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07357907.2016.1212205

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27559851

http://www.w3.org/2001/XMLSchema#string

Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells.

about

P2860

P2860

Small Molecule Survivin Inhibitor YM155 Displays Potent Activity Against Human Osteosarcoma Cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698